Cargando…

Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic

Detalles Bibliográficos
Autores principales: Kang, Lois, Goldman, Maya, Uyehara, Anny, Goldman, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/
http://dx.doi.org/10.1016/j.jaci.2020.12.603
_version_ 1783645337035997184
author Kang, Lois
Goldman, Maya
Uyehara, Anny
Goldman, Michael
author_facet Kang, Lois
Goldman, Maya
Uyehara, Anny
Goldman, Michael
author_sort Kang, Lois
collection PubMed
description
format Online
Article
Text
id pubmed-7849591
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78495912021-02-02 Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic Kang, Lois Goldman, Maya Uyehara, Anny Goldman, Michael J Allergy Clin Immunol Article Published by Mosby, Inc. 2021-02 2021-02-01 /pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603 Text en Copyright © 2020 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kang, Lois
Goldman, Maya
Uyehara, Anny
Goldman, Michael
Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title_full Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title_fullStr Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title_full_unstemmed Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title_short Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
title_sort safe subcutaneous immunotherapy dosing adjustments following prolonged interruptions in therapy due to covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/
http://dx.doi.org/10.1016/j.jaci.2020.12.603
work_keys_str_mv AT kanglois safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic
AT goldmanmaya safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic
AT uyeharaanny safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic
AT goldmanmichael safesubcutaneousimmunotherapydosingadjustmentsfollowingprolongedinterruptionsintherapyduetocovid19pandemic